Saturday, April 1, 2023
Home Breaking News Dear MULN Stock Fans, Mark Your Calendars for Oct. 27

Dear MULN Stock Fans, Mark Your Calendars for Oct. 27

InvestorPlace – Stock Market News, Stock Advice & Trading Tips

Mullen Automotive (NASDAQ:MULN) has kept busy in the last few weeks, announcing major news such as the $92 million bankruptcy acquisition of Electric Last Mile Solutions (NASDAQ:ELMSQ) and purchasing a majority stake in Bollinger Motors. The acquisition of ELMS’s manufacturing facility in Mishawaka, Indiana, will help the electric vehicle (EV) company speed up the release of the Bollinger B1 and 12 by at least 12 months. The facility will have a production capacity of up to 50,000 vehicles per year. Still, another MULN stock catalyst set for Oct. 27 is quickly approaching.

In about a week’s time, Mullen will host its “Strikingly Different” test-drive tour. It will take place across 19 cities in the U.S., starting with the Rose Bowl in Pasadena, California. Each event will last for two days and feature the unreleased Mullen Five SUV Crossover. The second city on the tour is Las Vegas, Nevada, which will take place on Nov. 10 and 11.

In Las Vegas, Mullen expects to showcase the Five RS as well, which boasts around 1,100 horsepower and speeds up to 200 miles per hour. In addition, the company hinted that there will be “other exciting features available” at the events. Both legs of the tour are already at full capacity.

Most Popular

CPMD Receives Cultivation License from Heath Canada | All Finance Times

$30 Million in Revenues Projected over 12 Months CannaPharmaRx ( OTCMKTS: CPMD ) announced on December 22nd, 2022, that Health Canada has...

Canadian Cannabis; Down but Far from Out – Growth for 2023 and Beyond

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - December 22, 2022) - Investorideas.com, a leading investor news resource covering cannabis and wellness...

CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million

CALGARY, AB, Dec. 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- CannaPharmaRx, Inc. (OTC PINK:CPMD)(the “Company”), an emerging...

CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million

CALGARY, AB / ACCESSWIRE / December 21, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD) (the "Company"), an emerging leader in development and operation...

Advertisement

Subscribe to our Stock News Alerts

Mobile is not required however if you want the fastest
delivery be sure to add your mobile.

Subscribe to our News Alerts
Loading